<?xml version="1.0" encoding="utf-8"?>
<RECORDS>
    <REC inst_id="1" recid="19873736" hot="yes" sortkey="3116817626" timescited="0">
        <item recid="19873736" sortkey="3116817626" dbyear="2006" Owner="NLM" Status="In-Process"
            dbweek="58" hasAbstract="Y">
            <i_ckey>KIM 0179070021FY</i_ckey>
            <pubyear>2007</pubyear>
            <edition>In-Process</edition>
            <TSAuthorList>
                <Entity>
                    <DisplayName ValidYN="Y">Kim, Yoon Seong</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Choi, Dong Hee</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Block, Michelle L</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Lorenzl, Stefan</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Yang, Lichuan</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Kim, Youn Jung</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Sugama, Shuei</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Cho, Byung Pil</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Hwang, Onyou</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Browne, Susan E</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Kim, Soo Yul</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Hong, Jau-Shyong</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Beal, M Flint</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Joh, Tong H</DisplayName>
                </Entity>
            </TSAuthorList>
            <EPubDate>
                <Year>2006</Year>
                <Month>Nov</Month>
                <Day>20</Day>
            </EPubDate>
            <PMID>17116747</PMID>
            <DateCreated>
                <Year>2006</Year>
                <Month>12</Month>
                <Day>29</Day>
            </DateCreated>
            <Article PubModel="Print-Electronic">
                <Journal>
                    <ISSN IssnType="Electronic">1530-6860</ISSN>
                    <JournalIssue CitedMedium="Internet">
                        <Volume>21</Volume>
                        <Issue>1</Issue>
                        <PubDate>
                            <Year>2007</Year>
                            <Month>Jan</Month>
                        </PubDate>
                    </JournalIssue>
                    <Title>The FASEB journal : official publication of the Federation of American
                        Societies for Experimental Biology</Title>
                    <ISOAbbreviation>FASEB J.</ISOAbbreviation>
                </Journal>
                <ArticleTitle>A pivotal role of matrix metalloproteinase-3 activity in dopaminergic
                    neuronal degeneration via microglial activation.</ArticleTitle>
                <Pagination>
                    <MedlinePgn>179-87</MedlinePgn>
                </Pagination>
                <Abstract>
                    <AbstractText>Recent studies have demonstrated that activated microglia play an
                        important role in dopamine (DA) neuronal degeneration in Parkinson disease
                        (PD) by generating NADPH-oxidase (NADPHO)-derived superoxide. However, the
                        molecular mechanisms that underlie microglial activation in DA cell death
                        are still disputed. We report here that matrix metalloproteinase-3 (MMP-3)
                        was newly induced and activated in stressed DA cells, and the active form of
                        MMP-3 (actMMP-3) was released into the medium. The released actMMP-3, as
                        well as catalytically active recombinant MMP-3 (cMMP-3) led to microglial
                        activation and superoxide generation in microglia and enhanced DA cell
                        death. cMMP-3 caused DA cell death in mesencephalic neuron-glia mixed
                        culture of wild-type (WT) mice, but this was attenuated in the culture of
                        NADPHO subunit null mice (gp91(phox-/-)), suggesting that NADPHO mediated
                        the cMMP-3-induced microglial production of superoxide and DA cell death.
                        Furthermore, in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
                        (MPTP)-injected animal model of PD, nigrostriatal DA neuronal degeneration,
                        microglial activation, and superoxide generation were largely attenuated in
                        MMP-3-/- mice. These results indicate that actMMP-3 released from stressed
                        DA neurons is responsible for microglial activation and generation of
                        NADPHO-derived superoxide and eventually enhances nigrostriatal DA neuronal
                        degeneration. Our results could lead to a novel therapeutic approach to
                    PD.</AbstractText>
                </Abstract>
                <Affiliation>Burke Medical Research Institute, and Department of Neurology and
                    Neuroscience, Weill Medical College of Cornell University, 1300 York Ave., New
                    York, NY 10021, USA.</Affiliation>
                <AuthorList CompleteYN="Y">
                    <Author ValidYN="Y">
                        <LastName>Kim</LastName>
                        <ForeName>Yoon Seong</ForeName>
                        <Initials>YS</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Choi</LastName>
                        <ForeName>Dong Hee</ForeName>
                        <Initials>DH</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Block</LastName>
                        <ForeName>Michelle L</ForeName>
                        <Initials>ML</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Lorenzl</LastName>
                        <ForeName>Stefan</ForeName>
                        <Initials>S</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Yang</LastName>
                        <ForeName>Lichuan</ForeName>
                        <Initials>L</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Kim</LastName>
                        <ForeName>Youn Jung</ForeName>
                        <Initials>YJ</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Sugama</LastName>
                        <ForeName>Shuei</ForeName>
                        <Initials>S</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Cho</LastName>
                        <ForeName>Byung Pil</ForeName>
                        <Initials>BP</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Hwang</LastName>
                        <ForeName>Onyou</ForeName>
                        <Initials>O</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Browne</LastName>
                        <ForeName>Susan E</ForeName>
                        <Initials>SE</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Kim</LastName>
                        <ForeName>Soo Yul</ForeName>
                        <Initials>SY</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Hong</LastName>
                        <ForeName>Jau-Shyong</ForeName>
                        <Initials>JS</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Beal</LastName>
                        <ForeName>M Flint</ForeName>
                        <Initials>MF</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Joh</LastName>
                        <ForeName>Tong H</ForeName>
                        <Initials>TH</Initials>
                    </Author>
                </AuthorList>
                <Language>eng</Language>
                <PublicationTypeList>
                    <PublicationType>Journal Article</PublicationType>
                    <PublicationType>Research Support, Non-U.S. Gov't</PublicationType>
                    <PublicationType>Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
                </PublicationTypeList>
                <ArticleDate DateType="Electronic">
                    <Year>2006</Year>
                    <Month>11</Month>
                    <Day>20</Day>
                </ArticleDate>
            </Article>
            <MedlineJournalInfo>
                <Country>United States</Country>
                <MedlineTA>FASEB J</MedlineTA>
                <NlmUniqueID>8804484</NlmUniqueID>
            </MedlineJournalInfo>
            <CitationSubset>IM</CitationSubset>
        </item>
    </REC>
    <REC inst_id="1" recid="19873546" hot="yes" sortkey="3116817816" timescited="0">
        <item recid="19873546" sortkey="3116817816" dbyear="2006" Owner="NLM"
            Status="In-Data-Review" dbweek="58" hasAbstract="Y">
            <i_ckey>ROIG0435060038AD</i_ckey>
            <pubyear>2006</pubyear>
            <edition>In-Process</edition>
            <TSAuthorList>
                <Entity>
                    <DisplayName ValidYN="Y">Roig Vilaseca, Daniel</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Valero, Carles</DisplayName>
                </Entity>
                <Entity>
                    <CollectiveName>on behalf of Grupo de estudio de criterios de derivacion a
                        densitometria</CollectiveName>
                </Entity>
            </TSAuthorList>
            <PMID>17194368</PMID>
            <DateCreated>
                <Year>2006</Year>
                <Month>12</Month>
                <Day>29</Day>
            </DateCreated>
            <Article PubModel="Print">
                <Journal>
                    <ISSN IssnType="Print">0212-6567</ISSN>
                    <JournalIssue CitedMedium="Print">
                        <Volume>38</Volume>
                        <Issue>8</Issue>
                        <PubDate>
                            <Year>2006</Year>
                            <Month>Nov</Month>
                            <Day>15</Day>
                        </PubDate>
                    </JournalIssue>
                    <Title>Atencion primaria / Sociedad Espanola de Medicina de Familia y
                        Comunitaria</Title>
                </Journal>
                <ArticleTitle>[Proportion of individuals with indication criteria for bone
                    densitometry and frequency of factors of risk of low osseous mass in primary
                    care consultations.]</ArticleTitle>
                <Pagination>
                    <MedlinePgn>435-42</MedlinePgn>
                </Pagination>
                <Abstract>
                    <AbstractText>OBJECTIVE. To find the number of individuals with indication for
                        Bone Densitometry in Primary Care, according to the criteria of the WHO, the
                        Agency for Evaluating Medical Technology of Catalonia (AETM) and the
                        International Committee on Clinical Guides to Osteoporosis (CIGCO), and the
                        frequency of factors of risk of low osseous mass. DESIGN. Multi-centre,
                        prospective, transversal study. SETTING. Primary care consultations.
                        PARTICIPANTS. Patients over 18 (307 women and 139 men) with mean age of
                        54.3+/-16.8, who attended for consultation with an appointment. MAIN
                        MEASUREMENTS. Presence or absence of factors relating to each of the
                        indication criteria for bone densitometry. RESULTS. A 36.3% of individuals
                        had indication of densitometry under the AETM criteria, 76.7% with the WHO
                        criteria, and 50.5% with the CIGCO criteria (applicable only to women).
                        Percentages increased with age and were higher for women. Concordance
                        between the various criteria was under 37%. CONCLUSIONS. The percentage of
                        individuals with indication for bone densitometry was highly variable under
                        different criteria. It was greater in women and increased with age.
                        Concordance between different criteria was low.</AbstractText>
                </Abstract>
                <Affiliation>Unidad de Reumatologia. SAP Baix Llobregat Centre. Cornella de
                    Llobregat. Barcelona. Espana.</Affiliation>
                <AuthorList CompleteYN="Y">
                    <Author ValidYN="Y">
                        <LastName>Roig Vilaseca</LastName>
                        <ForeName>Daniel</ForeName>
                        <Initials>D</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Valero</LastName>
                        <ForeName>Carles</ForeName>
                        <Initials>C</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <CollectiveName>on behalf of Grupo de estudio de criterios de derivacion a
                            densitometria</CollectiveName>
                    </Author>
                </AuthorList>
                <Language>spa</Language>
                <PublicationTypeList>
                    <PublicationType>English Abstract</PublicationType>
                    <PublicationType>Journal Article</PublicationType>
                </PublicationTypeList>
                <VernacularTitle>Proporcion de individuos con criterios de indicacion de
                    densitometria osea y frecuencia de los factores de riesgo de baja masa osea en
                    consultas de atencion primaria.</VernacularTitle>
            </Article>
            <MedlineJournalInfo>
                <Country>Spain</Country>
                <MedlineTA>Aten Primaria</MedlineTA>
                <NlmUniqueID>9111075</NlmUniqueID>
            </MedlineJournalInfo>
            <CitationSubset>IM</CitationSubset>
        </item>
    </REC>
    <REC inst_id="1" recid="19873128" hot="yes" sortkey="3116818234" timescited="0">
        <item recid="19873128" sortkey="3116818234" dbyear="2006" Owner="NLM" Status="In-Process"
            dbweek="58" hasAbstract="Y">
            <i_ckey>PIME0025070189RD</i_ckey>
            <pubyear>2007</pubyear>
            <edition>In-Process</edition>
            <TSAuthorList>
                <Entity>
                    <DisplayName ValidYN="Y">Pimentel, David</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Patzek, Tad</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Cecil, Gerald</DisplayName>
                </Entity>
            </TSAuthorList>
            <PMID>17193735</PMID>
            <DateCreated>
                <Year>2006</Year>
                <Month>12</Month>
                <Day>29</Day>
            </DateCreated>
            <Article PubModel="Print">
                <Journal>
                    <ISSN IssnType="Print">0179-5953</ISSN>
                    <JournalIssue CitedMedium="Print">
                        <Volume>189</Volume>
                        <PubDate>
                            <Year>2007</Year>
                        </PubDate>
                    </JournalIssue>
                    <Title>Reviews of environmental contamination and toxicology</Title>
                </Journal>
                <ArticleTitle>Ethanol production: energy, economic, and environmental losses.</ArticleTitle>
                <Pagination>
                    <MedlinePgn>25-41</MedlinePgn>
                </Pagination>
                <Abstract>
                    <AbstractText>The prime focus of ethanol production from corn is to replace the
                        imported oil used in American vehicles, without expending more fossil energy
                        in ethanol production than is produced as ethanol energy. In a thorough and
                        up-to-date evaluation of all the fossil energy costs of ethanol production
                        from corn, every step in the production and conversion process must be
                        included. In this study, 14 energy inputs in average U.S. corn production
                        are included. Then, in the fermentation/distillation operation, 9 more
                        identified fossil fuel inputs are included. Some energy and economic credits
                        are given for the by-products, including dried distillers grains (DDG).
                        Based on all the fossil energy inputs, a total of 1.43 kcal fossil energy is
                        expended to produced 1 kcal ethanol. When the energy value of the DDG, based
                        on the feed value of the DDG as compared to that of soybean meal, is
                        considered, the energy cost of ethanol production is reduced slightly, to
                        1.28 kcal fossil energy input per 1 kcal ethanol produced. Several
                        proethanol investigators have overlooked various energy inputs in U.S. corn
                        production, including farm machinery, processing machinery, and the use of
                        hybrid corn. In other studies, unrealistic, low energy costs were attributed
                        to such inputs as nitrogen fertilizer, insecticides, and herbicides.
                        Controversy continues concerning the energy and economic credits that should
                        be assigned to the by-products. The U.S. Department of Energy reports that
                        17.0 billion L ethanol was produced in 2005. This represents only less than
                        1% of total oil use in the U.S. These yields are based on using about 18% of
                        total U.S. corn production and 18% of cornland. Because the production of
                        ethanol requires large inputs of both oil and natural gas in production, the
                        U.S. is importing both oil and natural gas to produce ethanol. Furthermore,
                        the U.S. Government is spending about dollar 3 billion annually to subsidize
                        ethanol production, a subsidy of dollar 0.79/L ethanol produced. With the
                        subsidy, plus the cost of production, the cost of ethanol is calculated to
                        be dollar 1.21/L. The subsidy for a liter of ethanol is 45-times greater
                        than the subsidy per liter of gasoline. The environmental costs associated
                        with producing ethanol are significant but have been ignored by most
                        investigators in terms of energy and economics. The negative environmental
                        impacts on cropland, and freshwater, as well as air pollution and public
                        health, have yet to be carefully assessed. These environmental costs in
                        terms of energy and economics should be calculated and included in future
                        ethanol analyses. General concern has been expressed about taking 18% of
                        U.S. corn, and more in the future, to produce ethanol for burning in
                        automobiles instead of using the corn as food for the many malnourished
                        people in the world. The World Health Organization reports that more than
                        3.7 billion humans are currently malnourished in the world--the largest
                        number ever in history.</AbstractText>
                </Abstract>
                <Affiliation>College of Agriculture and Life Sciences, 5126 Comstock Hall, Cornell
                    University, Ithaca, NY 14853, USA.</Affiliation>
                <AuthorList CompleteYN="Y">
                    <Author ValidYN="Y">
                        <LastName>Pimentel</LastName>
                        <ForeName>David</ForeName>
                        <Initials>D</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Patzek</LastName>
                        <ForeName>Tad</ForeName>
                        <Initials>T</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Cecil</LastName>
                        <ForeName>Gerald</ForeName>
                        <Initials>G</Initials>
                    </Author>
                </AuthorList>
                <Language>eng</Language>
                <PublicationTypeList>
                    <PublicationType>Journal Article</PublicationType>
                </PublicationTypeList>
            </Article>
            <MedlineJournalInfo>
                <Country>United States</Country>
                <MedlineTA>Rev Environ Contam Toxicol</MedlineTA>
                <NlmUniqueID>8703602</NlmUniqueID>
            </MedlineJournalInfo>
            <CitationSubset>IM</CitationSubset>
        </item>
    </REC>
    <REC inst_id="1" recid="19873041" hot="yes" sortkey="3116818315" timescited="0">
        <item recid="19873041" sortkey="3116818315" dbyear="2006" Owner="NLM" Status="In-Process"
            dbweek="58" hasAbstract="N">
            <i_ckey>BURN0723060002SA</i_ckey>
            <pubyear>2006</pubyear>
            <edition>In-Process</edition>
            <TSAuthorList>
                <Entity>
                    <DisplayName ValidYN="Y">Burns, Andrew</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Sengupta, Prabuddha</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Zedayko, Tara</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Baird, Barbara</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Wiesner, Ulrich</DisplayName>
                </Entity>
            </TSAuthorList>
            <PMID>17193111</PMID>
            <DateCreated>
                <Year>2006</Year>
                <Month>12</Month>
                <Day>28</Day>
            </DateCreated>
            <Article PubModel="Print">
                <Journal>
                    <ISSN IssnType="Electronic">1613-6829</ISSN>
                    <JournalIssue CitedMedium="Internet">
                        <Volume>2</Volume>
                        <Issue>6</Issue>
                        <PubDate>
                            <Year>2006</Year>
                            <Month>Jun</Month>
                        </PubDate>
                    </JournalIssue>
                    <Title>Small (Weinheim an der Bergstrasse, Germany)</Title>
                </Journal>
                <ArticleTitle>Core/Shell fluorescent silica nanoparticles for chemical sensing:
                    towards single-particle laboratories.</ArticleTitle>
                <Pagination>
                    <MedlinePgn>723-6</MedlinePgn>
                </Pagination>
                <Affiliation>Department of Materials Science &amp; Engineering, 330 Bard Hall,
                    Cornell University, Ithaca, NY 14853, USA.</Affiliation>
                <AuthorList CompleteYN="Y">
                    <Author ValidYN="Y">
                        <LastName>Burns</LastName>
                        <ForeName>Andrew</ForeName>
                        <Initials>A</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Sengupta</LastName>
                        <ForeName>Prabuddha</ForeName>
                        <Initials>P</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Zedayko</LastName>
                        <ForeName>Tara</ForeName>
                        <Initials>T</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Baird</LastName>
                        <ForeName>Barbara</ForeName>
                        <Initials>B</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Wiesner</LastName>
                        <ForeName>Ulrich</ForeName>
                        <Initials>U</Initials>
                    </Author>
                </AuthorList>
                <Language>eng</Language>
                <PublicationTypeList>
                    <PublicationType>Journal Article</PublicationType>
                    <PublicationType>Research Support, Non-U.S. Gov't</PublicationType>
                    <PublicationType>Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
                </PublicationTypeList>
            </Article>
            <MedlineJournalInfo>
                <Country>Germany</Country>
                <MedlineTA>Small</MedlineTA>
                <NlmUniqueID>101235338</NlmUniqueID>
            </MedlineJournalInfo>
            <CitationSubset>IM</CitationSubset>
        </item>
    </REC>
    <REC inst_id="1" recid="19873024" hot="yes" sortkey="3116818328" timescited="0">
        <item recid="19873024" sortkey="3116818328" dbyear="2006" Owner="NLM" Status="In-Process"
            dbweek="58" hasAbstract="N">
            <i_ckey>LIU 0495060002SH</i_ckey>
            <pubyear>2006</pubyear>
            <edition>In-Process</edition>
            <TSAuthorList>
                <Entity>
                    <DisplayName ValidYN="Y">Liu, Haiqing</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Edel, Joshua B</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Bellan, Leon M</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Craighead, H G</DisplayName>
                </Entity>
            </TSAuthorList>
            <PMID>17193073</PMID>
            <DateCreated>
                <Year>2006</Year>
                <Month>12</Month>
                <Day>28</Day>
            </DateCreated>
            <Article PubModel="Print">
                <Journal>
                    <ISSN IssnType="Electronic">1613-6829</ISSN>
                    <JournalIssue CitedMedium="Internet">
                        <Volume>2</Volume>
                        <Issue>4</Issue>
                        <PubDate>
                            <Year>2006</Year>
                            <Month>Apr</Month>
                        </PubDate>
                    </JournalIssue>
                    <Title>Small (Weinheim an der Bergstrasse, Germany)</Title>
                </Journal>
                <ArticleTitle>Electrospun polymer nanofibers as subwavelength optical waveguides
                    incorporating quantum dots.</ArticleTitle>
                <Pagination>
                    <MedlinePgn>495-9</MedlinePgn>
                </Pagination>
                <Affiliation>School of Applied and Engineering Physics and Nanobiotechnology Center,
                    Cornell University, Ithaca, NY 14853, USA.</Affiliation>
                <AuthorList CompleteYN="Y">
                    <Author ValidYN="Y">
                        <LastName>Liu</LastName>
                        <ForeName>Haiqing</ForeName>
                        <Initials>H</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Edel</LastName>
                        <ForeName>Joshua B</ForeName>
                        <Initials>JB</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Bellan</LastName>
                        <ForeName>Leon M</ForeName>
                        <Initials>LM</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Craighead</LastName>
                        <ForeName>H G</ForeName>
                        <Initials>HG</Initials>
                    </Author>
                </AuthorList>
                <Language>eng</Language>
                <PublicationTypeList>
                    <PublicationType>Journal Article</PublicationType>
                    <PublicationType>Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
                </PublicationTypeList>
            </Article>
            <MedlineJournalInfo>
                <Country>Germany</Country>
                <MedlineTA>Small</MedlineTA>
                <NlmUniqueID>101235338</NlmUniqueID>
            </MedlineJournalInfo>
            <CitationSubset>IM</CitationSubset>
        </item>
    </REC>
    <REC inst_id="1" recid="19872828" hot="yes" sortkey="3116818499" timescited="0">
        <item recid="19872828" sortkey="3116818499" dbyear="2006" Owner="NLM" Status="In-Process"
            dbweek="58" hasAbstract="N">
            <i_ckey>BOUR0080050001SA</i_ckey>
            <pubyear>2005</pubyear>
            <edition>In-Process</edition>
            <TSAuthorList>
                <Entity>
                    <DisplayName ValidYN="Y">Bourlinos, Athanasios B</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Chowdhury, Subhendu Ray</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Jiang, David D</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">An, Yeong-U</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Zhang, Qiang</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Archer, Lynden A</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Giannelis, Emmanuel P</DisplayName>
                </Entity>
            </TSAuthorList>
            <PMID>17193353</PMID>
            <DateCreated>
                <Year>2006</Year>
                <Month>12</Month>
                <Day>28</Day>
            </DateCreated>
            <Article PubModel="Print">
                <Journal>
                    <ISSN IssnType="Electronic">1613-6829</ISSN>
                    <JournalIssue CitedMedium="Internet">
                        <Volume>1</Volume>
                        <Issue>1</Issue>
                        <PubDate>
                            <Year>2005</Year>
                            <Month>Jan</Month>
                        </PubDate>
                    </JournalIssue>
                    <Title>Small (Weinheim an der Bergstrasse, Germany)</Title>
                </Journal>
                <ArticleTitle>Layered organosilicate nanoparticles with liquidlike behavior.</ArticleTitle>
                <Pagination>
                    <MedlinePgn>80-2</MedlinePgn>
                </Pagination>
                <Affiliation>Department of Materials Science and Engineering, Cornell University,
                    Ithaca 14853, NY, USA.</Affiliation>
                <AuthorList CompleteYN="Y">
                    <Author ValidYN="Y">
                        <LastName>Bourlinos</LastName>
                        <ForeName>Athanasios B</ForeName>
                        <Initials>AB</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Chowdhury</LastName>
                        <ForeName>Subhendu Ray</ForeName>
                        <Initials>SR</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Jiang</LastName>
                        <ForeName>David D</ForeName>
                        <Initials>DD</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>An</LastName>
                        <ForeName>Yeong-U</ForeName>
                        <Initials>YU</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Zhang</LastName>
                        <ForeName>Qiang</ForeName>
                        <Initials>Q</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Archer</LastName>
                        <ForeName>Lynden A</ForeName>
                        <Initials>LA</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Giannelis</LastName>
                        <ForeName>Emmanuel P</ForeName>
                        <Initials>EP</Initials>
                    </Author>
                </AuthorList>
                <Language>eng</Language>
                <PublicationTypeList>
                    <PublicationType>Journal Article</PublicationType>
                    <PublicationType>Research Support, Non-U.S. Gov't</PublicationType>
                </PublicationTypeList>
            </Article>
            <MedlineJournalInfo>
                <Country>Germany</Country>
                <MedlineTA>Small</MedlineTA>
                <NlmUniqueID>101235338</NlmUniqueID>
            </MedlineJournalInfo>
            <CitationSubset>IM</CitationSubset>
        </item>
    </REC>
    <REC inst_id="1" recid="19868877" hot="yes" sortkey="3116819075" timescited="0">
        <item recid="19868877" sortkey="3116819075" dbyear="2006" Owner="NLM"
            Status="In-Data-Review" dbweek="58" hasAbstract="Y">
            <i_ckey>JOHN0061070009OJ</i_ckey>
            <pubyear>2007</pubyear>
            <edition>In-Process</edition>
            <TSAuthorList>
                <Entity>
                    <DisplayName ValidYN="Y">John, Jinu P</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Novikov, Alexei V</DisplayName>
                </Entity>
            </TSAuthorList>
            <PMID>17192085</PMID>
            <DateCreated>
                <Year>2006</Year>
                <Month>12</Month>
                <Day>28</Day>
            </DateCreated>
            <Article PubModel="Print">
                <Journal>
                    <ISSN IssnType="Print">1523-7060</ISSN>
                    <JournalIssue CitedMedium="Print">
                        <Volume>9</Volume>
                        <Issue>1</Issue>
                        <PubDate>
                            <Year>2007</Year>
                            <Month>Jan</Month>
                            <Day>4</Day>
                        </PubDate>
                    </JournalIssue>
                    <Title>Organic letters</Title>
                    <ISOAbbreviation>Org. Lett.</ISOAbbreviation>
                </Journal>
                <ArticleTitle>Selective formation of six-membered cyclic sulfones and sulfonates by
                    C-h insertion.</ArticleTitle>
                <Pagination>
                    <MedlinePgn>61-3</MedlinePgn>
                </Pagination>
                <Abstract>
                    <AbstractText>Carbethoxy diazosulfones and sulfonates, easily available from
                        corresponding sulfones and sulfonates, undergo C-H insertion with
                        preferential formation of six membered cyclic sulfones and
                    sulfonates.</AbstractText>
                </Abstract>
                <Affiliation>Chemistry Department, University of North Dakota, 151 Cornell Street
                    Stop 9024, Grand Forks, North Dakota 58202.</Affiliation>
                <AuthorList CompleteYN="Y">
                    <Author ValidYN="Y">
                        <LastName>John</LastName>
                        <ForeName>Jinu P</ForeName>
                        <Initials>JP</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Novikov</LastName>
                        <ForeName>Alexei V</ForeName>
                        <Initials>AV</Initials>
                    </Author>
                </AuthorList>
                <Language>eng</Language>
                <PublicationTypeList>
                    <PublicationType>Journal Article</PublicationType>
                </PublicationTypeList>
            </Article>
            <MedlineJournalInfo>
                <Country>United States</Country>
                <MedlineTA>Org Lett</MedlineTA>
                <NlmUniqueID>100890393</NlmUniqueID>
            </MedlineJournalInfo>
            <CitationSubset>IM</CitationSubset>
        </item>
    </REC>
    <REC inst_id="1" recid="19868855" hot="yes" sortkey="3116819097" timescited="0">
        <item recid="19868855" sortkey="3116819097" dbyear="2006" Owner="NLM"
            Status="In-Data-Review" dbweek="58" hasAbstract="Y">
            <i_ckey>BANG0188060027NH</i_ckey>
            <pubyear>2006</pubyear>
            <edition>In-Process</edition>
            <TSAuthorList>
                <Entity>
                    <DisplayName ValidYN="Y">Bang, Heejung</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Mazumdar, Madhu</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Spence, David</DisplayName>
                </Entity>
            </TSAuthorList>
            <EPubDate>
                <Year>2006</Year>
                <Month>Oct</Month>
                <Day>11</Day>
            </EPubDate>
            <PMID>17035715</PMID>
            <DateCreated>
                <Year>2006</Year>
                <Month>12</Month>
                <Day>28</Day>
            </DateCreated>
            <Article PubModel="Print-Electronic">
                <Journal>
                    <ISSN IssnType="Print">0251-5350</ISSN>
                    <JournalIssue CitedMedium="Print">
                        <Volume>27</Volume>
                        <Issue>4</Issue>
                        <PubDate>
                            <Year>2006</Year>
                        </PubDate>
                    </JournalIssue>
                    <Title>Neuroepidemiology</Title>
                </Journal>
                <ArticleTitle>Tutorial in Biostatistics: Analyzing Associations between Total Plasma
                    Homocysteine and B Vitamins Using Optimal Categorization and Segmented
                    Regression.</ArticleTitle>
                <Pagination>
                    <MedlinePgn>188-200</MedlinePgn>
                </Pagination>
                <Abstract>
                    <AbstractText>Data analysts consider standard regression models (e.g.,
                        generalized linear model) or nonparametric smoothing techniques (e.g., loess
                        or splines) when examining the association between two variables. Before
                        this step, a quantile-based summarization is typically used for exploring
                        the exposure-response relationship. Unfortunately, these exploratory
                        approaches may not be optimal or efficient for guiding the formal analysis
                        in many biological and nutritional data settings. We suggest a recently
                        developed method for selection of cutpoints as a tool of data summary and
                        segmented regression as a modeling approach in the analysis of plasma total
                        homocysteine and related vitamins. These methods are often complementary in
                        discovering the underlying complex pattern of association. Copyright (c)
                        2006 S. Karger AG, Basel.</AbstractText>
                </Abstract>
                <Affiliation>Division of Biostatistics and Epidemiology, Department of Public
                    Health, Weill Medical College of Cornell University, New York, N.Y., USA.</Affiliation>
                <AuthorList CompleteYN="Y">
                    <Author ValidYN="Y">
                        <LastName>Bang</LastName>
                        <ForeName>Heejung</ForeName>
                        <Initials>H</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Mazumdar</LastName>
                        <ForeName>Madhu</ForeName>
                        <Initials>M</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Spence</LastName>
                        <ForeName>David</ForeName>
                        <Initials>D</Initials>
                    </Author>
                </AuthorList>
                <Language>eng</Language>
                <PublicationTypeList>
                    <PublicationType>Journal Article</PublicationType>
                </PublicationTypeList>
                <ArticleDate DateType="Electronic">
                    <Year>2006</Year>
                    <Month>10</Month>
                    <Day>11</Day>
                </ArticleDate>
            </Article>
            <MedlineJournalInfo>
                <Country>Switzerland</Country>
                <MedlineTA>Neuroepidemiology</MedlineTA>
                <NlmUniqueID>8218700</NlmUniqueID>
            </MedlineJournalInfo>
            <CitationSubset>IM</CitationSubset>
        </item>
    </REC>
    <REC inst_id="1" recid="19868799" hot="yes" sortkey="3116819153" timescited="0">
        <item recid="19868799" sortkey="3116819153" dbyear="2006" Owner="NLM" Status="In-Process"
            dbweek="58" hasAbstract="N">
            <i_ckey>FRIE2717060355NR</i_ckey>
            <pubyear>2006</pubyear>
            <edition>In-Process</edition>
            <TSAuthorList>
                <Entity>
                    <DisplayName ValidYN="Y">Friedman, Richard A</DisplayName>
                </Entity>
            </TSAuthorList>
            <PMID>17192534</PMID>
            <DateCreated>
                <Year>2006</Year>
                <Month>12</Month>
                <Day>28</Day>
            </DateCreated>
            <Article PubModel="Print">
                <Journal>
                    <ISSN IssnType="Electronic">1533-4406</ISSN>
                    <JournalIssue CitedMedium="Internet">
                        <Volume>355</Volume>
                        <Issue>26</Issue>
                        <PubDate>
                            <Year>2006</Year>
                            <Month>Dec</Month>
                            <Day>28</Day>
                        </PubDate>
                    </JournalIssue>
                    <Title>The New England journal of medicine</Title>
                    <ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
                </Journal>
                <ArticleTitle>Uncovering an epidemic--screening for mental illness in teens.</ArticleTitle>
                <Pagination>
                    <MedlinePgn>2717-9</MedlinePgn>
                </Pagination>
                <Affiliation>Psychopharmacology Clinic at Weill Cornell Medical College, New York,
                    USA.</Affiliation>
                <AuthorList CompleteYN="Y">
                    <Author ValidYN="Y">
                        <LastName>Friedman</LastName>
                        <ForeName>Richard A</ForeName>
                        <Initials>RA</Initials>
                    </Author>
                </AuthorList>
                <Language>eng</Language>
                <PublicationTypeList>
                    <PublicationType>Journal Article</PublicationType>
                </PublicationTypeList>
            </Article>
            <MedlineJournalInfo>
                <Country>United States</Country>
                <MedlineTA>N Engl J Med</MedlineTA>
                <NlmUniqueID>0255562</NlmUniqueID>
            </MedlineJournalInfo>
            <CitationSubset>AIM</CitationSubset>
            <CitationSubset>IM</CitationSubset>
        </item>
    </REC>
    <REC inst_id="1" recid="19868712" hot="yes" sortkey="3116819240" timescited="0">
        <item recid="19868712" sortkey="3116819240" dbyear="2006" Owner="NLM"
            Status="In-Data-Review" dbweek="58" hasAbstract="Y">
            <i_ckey>BAIN0800070081JJ</i_ckey>
            <pubyear>2007</pubyear>
            <edition>In-Process</edition>
            <TSAuthorList>
                <Entity>
                    <DisplayName ValidYN="Y">Baines, Joel D</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Wills, Elizabeth</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Jacob, Robert J</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Pennington, Janice</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Roizman, Bernard</DisplayName>
                </Entity>
            </TSAuthorList>
            <EPubDate>
                <Year>2006</Year>
                <Month>Nov</Month>
                <Day>01</Day>
            </EPubDate>
            <PMID>17079321</PMID>
            <DateCreated>
                <Year>2006</Year>
                <Month>12</Month>
                <Day>28</Day>
            </DateCreated>
            <Article PubModel="Print-Electronic">
                <Journal>
                    <ISSN IssnType="Print">0022-538X</ISSN>
                    <JournalIssue CitedMedium="Print">
                        <Volume>81</Volume>
                        <Issue>2</Issue>
                        <PubDate>
                            <Year>2007</Year>
                            <Month>Jan</Month>
                        </PubDate>
                    </JournalIssue>
                    <Title>Journal of virology</Title>
                    <ISOAbbreviation>J. Virol.</ISOAbbreviation>
                </Journal>
                <ArticleTitle>Glycoprotein M of Herpes Simplex Virus 1 Is Incorporated into Virions
                    during Budding at the Inner Nuclear Membrane.</ArticleTitle>
                <Pagination>
                    <MedlinePgn>800-12</MedlinePgn>
                </Pagination>
                <Abstract>
                    <AbstractText>It is widely accepted that nucleocapsids of herpesviruses bud
                        through the inner nuclear membrane (INM), but few studies have been
                        undertaken to characterize the composition of these nascent virions. Such
                        knowledge would shed light on the budding reaction at the INM and subsequent
                        steps in the egress pathway. The present study focuses on glycoprotein M
                        (gM), a type III integral membrane protein of herpes simplex virus 1 (HSV-1)
                        that likely contains eight transmembrane domains. The results indicated that
                        gM localized primarily at the perinuclear region, with especially bright
                        staining near the nuclear membrane (NM). Immunogold electron microscopic
                        analysis indicated that, like gB and gD (M. R. Torrisi et al., J. Virol.
                        66:554-561, 1992), gM localized within both leaflets of the NM, the
                        envelopes of nascent virions that accumulate in the perinuclear space, and
                        the envelopes of cytoplasmic and mature extracellular virus particles.
                        Indirect immunofluorescence studies revealed that gM colocalized almost
                        completely with a marker of the Golgi apparatus and partially with a marker
                        of the trans-Golgi network (TGN), whether or not these markers were
                        displaced to the perinuclear region during infection. gM was also located in
                        punctate extensions and invaginations of the NM induced by the absence of a
                        viral kinase encoded by HSV-1 U(S)3 and within virions located in these
                        extensions. Our findings therefore support the proposition that gM, like gB
                        and gD, becomes incorporated into the virion envelope upon budding through
                        the INM. The localization of viral glycoproteins and Golgi and TGN markers
                        to a perinuclear region may represent a mechanism to facilitate the
                        production of infectious nascent virions, thereby increasing the amount of
                        infectivity released upon cellular lysis.</AbstractText>
                </Abstract>
                <Affiliation>C5169 Veterinary Education Center, Cornell University, Ithaca, NY
                    14853. jdb11@cornell.edu.</Affiliation>
                <AuthorList CompleteYN="Y">
                    <Author ValidYN="Y">
                        <LastName>Baines</LastName>
                        <ForeName>Joel D</ForeName>
                        <Initials>JD</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Wills</LastName>
                        <ForeName>Elizabeth</ForeName>
                        <Initials>E</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Jacob</LastName>
                        <ForeName>Robert J</ForeName>
                        <Initials>RJ</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Pennington</LastName>
                        <ForeName>Janice</ForeName>
                        <Initials>J</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Roizman</LastName>
                        <ForeName>Bernard</ForeName>
                        <Initials>B</Initials>
                    </Author>
                </AuthorList>
                <Language>eng</Language>
                <PublicationTypeList>
                    <PublicationType>Journal Article</PublicationType>
                </PublicationTypeList>
                <ArticleDate DateType="Electronic">
                    <Year>2006</Year>
                    <Month>11</Month>
                    <Day>01</Day>
                </ArticleDate>
            </Article>
            <MedlineJournalInfo>
                <Country>United States</Country>
                <MedlineTA>J Virol</MedlineTA>
                <NlmUniqueID>0113724</NlmUniqueID>
            </MedlineJournalInfo>
            <CitationSubset>IM</CitationSubset>
        </item>
    </REC>
    <REC inst_id="1" recid="19868537" hot="yes" sortkey="3116819415" timescited="0">
        <item recid="19868537" sortkey="3116819415" dbyear="2006" Owner="NLM"
            Status="In-Data-Review" dbweek="58" hasAbstract="Y">
            <i_ckey>TANG0165070048JX</i_ckey>
            <pubyear>2007</pubyear>
            <edition>In-Process</edition>
            <TSAuthorList>
                <Entity>
                    <DisplayName ValidYN="Y">Tang, Xiao-Han</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Suh, Moo-Jin</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Li, Rong</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Gudas, Lorraine J</DisplayName>
                </Entity>
            </TSAuthorList>
            <EPubDate>
                <Year>2006</Year>
                <Month>Oct</Month>
                <Day>26</Day>
            </EPubDate>
            <PMID>17068359</PMID>
            <DateCreated>
                <Year>2006</Year>
                <Month>12</Month>
                <Day>28</Day>
            </DateCreated>
            <Article PubModel="Print-Electronic">
                <Journal>
                    <ISSN IssnType="Print">0022-2275</ISSN>
                    <JournalIssue CitedMedium="Print">
                        <Volume>48</Volume>
                        <Issue>1</Issue>
                        <PubDate>
                            <Year>2007</Year>
                            <Month>Jan</Month>
                        </PubDate>
                    </JournalIssue>
                    <Title>Journal of lipid research</Title>
                    <ISOAbbreviation>J. Lipid Res.</ISOAbbreviation>
                </Journal>
                <ArticleTitle>Cell proliferation inhibition and alterations in retinol
                    esterification induced by phytanic acid and docosahexaenoic acid.</ArticleTitle>
                <Pagination>
                    <MedlinePgn>165-76</MedlinePgn>
                </Pagination>
                <Abstract>
                    <AbstractText>We investigated the effects of two natural dietary retinoid X
                        receptor (RXR) ligands, phytanic acid (PA) and docosahexaenoic acid (DHA),
                        on proliferation and on the metabolism of retinol (vitamin A) in both
                        cultured normal human prostate epithelial cells (PrECs) and PC-3 prostate
                        carcinoma cells. PA and DHA inhibited the proliferation of the parental PC-3
                        cells and PC-3 cells engineered to overexpress human lecithin:retinol
                        acyltransferase (LRAT) in both the absence and presence of retinol. A
                        synthetic RXR-specific ligand also inhibited PC-3 cell proliferation,
                        whereas all-trans retinoic acid (ATRA) did not. PA and DHA treatment
                        increased the levels of retinyl esters (REs) in both PrECs and PC-3 cells
                        and generated novel REs that eluted on reverse-phase HPLC at 54.0 and 50.5
                        min, respectively. Mass spectrometric analyses demonstrated that these novel
                        REs were retinyl phytanate (54.0 min) and retinyl docosahexaenoate (50.5
                        min). Neither PA nor DHA increased LRAT mRNA levels in these cells. In
                        addition, we demonstrate that retinyl phytanate was generated by LRAT in the
                        presence of PA and retinol; however, retinyl docosahexaenoate was produced
                        by another enzyme in the presence of DHA and retinol.</AbstractText>
                </Abstract>
                <Affiliation>Department of Pharmacology, Weill Medical College of Cornell
                    University, New York, NY 10021.</Affiliation>
                <AuthorList CompleteYN="Y">
                    <Author ValidYN="Y">
                        <LastName>Tang</LastName>
                        <ForeName>Xiao-Han</ForeName>
                        <Initials>XH</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Suh</LastName>
                        <ForeName>Moo-Jin</ForeName>
                        <Initials>MJ</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Li</LastName>
                        <ForeName>Rong</ForeName>
                        <Initials>R</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Gudas</LastName>
                        <ForeName>Lorraine J</ForeName>
                        <Initials>LJ</Initials>
                    </Author>
                </AuthorList>
                <Language>eng</Language>
                <PublicationTypeList>
                    <PublicationType>Journal Article</PublicationType>
                </PublicationTypeList>
                <ArticleDate DateType="Electronic">
                    <Year>2006</Year>
                    <Month>10</Month>
                    <Day>26</Day>
                </ArticleDate>
            </Article>
            <MedlineJournalInfo>
                <Country>United States</Country>
                <MedlineTA>J Lipid Res</MedlineTA>
                <NlmUniqueID>0376606</NlmUniqueID>
            </MedlineJournalInfo>
            <CitationSubset>IM</CitationSubset>
        </item>
    </REC>
    <REC inst_id="1" recid="19867622" hot="yes" sortkey="3116820218" timescited="0">
        <item recid="19867622" sortkey="3116820218" dbyear="2006" Owner="NLM"
            Status="In-Data-Review" dbweek="58" hasAbstract="Y">
            <i_ckey>FARZ3918060054AA</i_ckey>
            <pubyear>2006</pubyear>
            <edition>In-Process</edition>
            <TSAuthorList>
                <Entity>
                    <DisplayName ValidYN="Y">Farzaneh-Far, Afshin</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Roman, Mary J</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Lockshin, Michael D</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Devereux, Richard B</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Paget, Stephen A</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Crow, Mary K</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Davis, Adrienne</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Sammaritano, Lisa</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Levine, Daniel M</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Salmon, Jane E</DisplayName>
                </Entity>
            </TSAuthorList>
            <PMID>17133599</PMID>
            <DateCreated>
                <Year>2006</Year>
                <Month>12</Month>
                <Day>28</Day>
            </DateCreated>
            <Article PubModel="Print">
                <Journal>
                    <ISSN IssnType="Print">0004-3591</ISSN>
                    <JournalIssue CitedMedium="Print">
                        <Volume>54</Volume>
                        <Issue>12</Issue>
                        <PubDate>
                            <Year>2006</Year>
                            <Month>Dec</Month>
                        </PubDate>
                    </JournalIssue>
                    <Title>Arthritis and rheumatism</Title>
                    <ISOAbbreviation>Arthritis Rheum.</ISOAbbreviation>
                </Journal>
                <ArticleTitle>Relationship of antiphospholipid antibodies to cardiovascular
                    manifestations of systemic lupus erythematosus.</ArticleTitle>
                <Pagination>
                    <MedlinePgn>3918-25</MedlinePgn>
                </Pagination>
                <Abstract>
                    <AbstractText>OBJECTIVE: Although antiphospholipid antibodies (aPL) are
                        associated with arterial and venous thrombosis in systemic lupus
                        erythematosus (SLE), the extent to which they influence other cardiovascular
                        manifestations is either controversial or uncertain. We undertook this study
                        to examine the relationships of aPL with valvular, myocardial, and arterial
                        disease in SLE. METHODS: Two hundred patients in an SLE registry, recruited
                        at the time of outpatient visits, underwent comprehensive interviews,
                        physical examinations, laboratory assessments, echocardiography to assess
                        left ventricular (LV) and valvular status, carotid ultrasonography to detect
                        atherosclerosis (discrete plaque), and radial applanation tonometry to
                        measure arterial stiffness. RESULTS: Antiphospholipid antibodies were
                        present(defined as IgG or IgM anticardiolipin &gt;/=40 IU/ml or the
                        presence of lupus anticoagulant) in 42 patients (21%). Mitral valve nodules
                        and moderate-to-severe mitral regurgitation were more common in aPL-positive
                        patients (both 14.3% versus 4.4%; P = 0.02). Thirty-one percent of patients
                        with high titers of IgG aPL (&gt;80 IU/ml) had mitral valve nodules,
                        compared with 20% of patients with mildly to moderately elevated levels of
                        IgG aPL (16-80 IU/ml) and 4% of patients without IgG aPL (overall P &lt;
                        0.001). Levels of soluble tumor necrosis factor receptors were higher in the
                        presence of both aPL and mitral valve nodules. LV dimensions, systolic
                        function, and carotid artery stiffness as well as prevalences of Raynaud's
                        phenomenon, pulmonary hypertension, and atherosclerosis were similar in
                        aPL-positive and aPL-negative patients. CONCLUSION: Antiphospholipid
                        antibodies in SLE are associated with mitral valve nodules and significant
                        mitral regurgitation, possibly due to valvular endothelial cell activation.
                        However, in this population, they are not associated with evidence of
                        myocardial hypertrophy, systolic dysfunction, coronary or carotid
                        atherosclerosis, or other vascular abnormalities.</AbstractText>
                </Abstract>
                <Affiliation>Hospital for Special Surgery, and Weill Medical College of Cornell
                    University, New York, New York.</Affiliation>
                <AuthorList CompleteYN="Y">
                    <Author ValidYN="Y">
                        <LastName>Farzaneh-Far</LastName>
                        <ForeName>Afshin</ForeName>
                        <Initials>A</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Roman</LastName>
                        <ForeName>Mary J</ForeName>
                        <Initials>MJ</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Lockshin</LastName>
                        <ForeName>Michael D</ForeName>
                        <Initials>MD</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Devereux</LastName>
                        <ForeName>Richard B</ForeName>
                        <Initials>RB</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Paget</LastName>
                        <ForeName>Stephen A</ForeName>
                        <Initials>SA</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Crow</LastName>
                        <ForeName>Mary K</ForeName>
                        <Initials>MK</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Davis</LastName>
                        <ForeName>Adrienne</ForeName>
                        <Initials>A</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Sammaritano</LastName>
                        <ForeName>Lisa</ForeName>
                        <Initials>L</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Levine</LastName>
                        <ForeName>Daniel M</ForeName>
                        <Initials>DM</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Salmon</LastName>
                        <ForeName>Jane E</ForeName>
                        <Initials>JE</Initials>
                    </Author>
                </AuthorList>
                <Language>eng</Language>
                <PublicationTypeList>
                    <PublicationType>Journal Article</PublicationType>
                </PublicationTypeList>
            </Article>
            <MedlineJournalInfo>
                <Country>United States</Country>
                <MedlineTA>Arthritis Rheum</MedlineTA>
                <NlmUniqueID>0370605</NlmUniqueID>
            </MedlineJournalInfo>
            <CitationSubset>AIM</CitationSubset>
            <CitationSubset>IM</CitationSubset>
        </item>
    </REC>
    <REC inst_id="1" recid="19867575" hot="yes" sortkey="3116820265" timescited="0">
        <item recid="19867575" sortkey="3116820265" dbyear="2006" Owner="NLM"
            Status="In-Data-Review" dbweek="58" hasAbstract="Y">
            <i_ckey>SEIF0195061088AK</i_ckey>
            <pubyear>2006</pubyear>
            <edition>In-Process</edition>
            <TSAuthorList>
                <Entity>
                    <DisplayName ValidYN="Y">Seiffert, Kristina</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Granstein, Richard D</DisplayName>
                </Entity>
            </TSAuthorList>
            <PMID>17192566</PMID>
            <DateCreated>
                <Year>2006</Year>
                <Month>12</Month>
                <Day>28</Day>
            </DateCreated>
            <Article PubModel="Print">
                <Journal>
                    <ISSN IssnType="Print">0077-8923</ISSN>
                    <JournalIssue CitedMedium="Print">
                        <Volume>1088</Volume>
                        <PubDate>
                            <Year>2006</Year>
                            <Month>Nov</Month>
                        </PubDate>
                    </JournalIssue>
                    <Title>Annals of the New York Academy of Sciences</Title>
                    <ISOAbbreviation>Ann. N. Y. Acad. Sci.</ISOAbbreviation>
                </Journal>
                <ArticleTitle>Neuroendocrine regulation of skin dendritic cells.</ArticleTitle>
                <Pagination>
                    <MedlinePgn>195-206</MedlinePgn>
                </Pagination>
                <Abstract>
                    <AbstractText>It has long been postulated that stress can affect certain skin
                        conditions, and there is increasing experimental evidence that the
                        neuroendocrine system can directly participate in cutaneous inflammation.
                        Neurohormones, such as glucocorticoids and catecholamines, can reach the
                        skin through the bloodstream after activation of the
                        hypothalamic-pituitary-adrenal axis and the sympathetic nervous system,
                        respectively. Multiple neuropeptides, among them calcitonin gene-related
                        peptide, alpha-melanocyte stimulating hormone, pituitary adenylate
                        cyclase-activating peptide, substance P, vasoactive intestinal peptide, and
                        norepinephrine, may be released by cutaneous nerves or resident and
                        infiltrating cells within the skin. Systemic neuromediators and cutaneous
                        nerves can influence a number of target cells within the skin, among them
                        Langerhans cells. Most of the experimental evidence to date indicates a
                        suppressive effect of the neurohormones and neuropeptides on Langerhans cell
                        function and cutaneous inflammation, but it has become evident lately that
                        the timing of exposure to a stimulus is critical to the outcome of the
                        immune response. Thus, administration of a stress hormone or exposure to a
                        stressor before the dendritic cell (DC) encounters an antigen (Ag) may
                        diminish the immune response toward that Ag, while a stressor may enhance
                        immune function when acting on a maturing DC or before reexposure to the Ag.
                        The neuroendocrine regulation of skin DCs is a complex system allowing for a
                        quick adaptation to various stressors. Such a system, originally evolved to
                        defend the organism against invading pathogens and maintain homeostasis, may
                        under certain conditions become unbalanced and ultimately exacerbate
                        cutaneous inflammation.</AbstractText>
                </Abstract>
                <Affiliation>Department of Dermatology, Weill Medical College of Cornell University,
                    525 East 68th Street, Rm. 340, New York 10021, NY. rdgranst@med.cornell.edu.</Affiliation>
                <AuthorList CompleteYN="Y">
                    <Author ValidYN="Y">
                        <LastName>Seiffert</LastName>
                        <ForeName>Kristina</ForeName>
                        <Initials>K</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Granstein</LastName>
                        <ForeName>Richard D</ForeName>
                        <Initials>RD</Initials>
                    </Author>
                </AuthorList>
                <Language>eng</Language>
                <PublicationTypeList>
                    <PublicationType>Journal Article</PublicationType>
                </PublicationTypeList>
            </Article>
            <MedlineJournalInfo>
                <Country>United States</Country>
                <MedlineTA>Ann N Y Acad Sci</MedlineTA>
                <NlmUniqueID>7506858</NlmUniqueID>
            </MedlineJournalInfo>
            <CitationSubset>IM</CitationSubset>
        </item>
    </REC>
    <REC inst_id="1" recid="19866608" hot="yes" sortkey="3116820851" timescited="0">
        <item recid="19866608" sortkey="3116820851" dbyear="2006" Owner="NLM" Status="In-Process"
            dbweek="58" hasAbstract="Y">
            <i_ckey>KRIS1255060022LS</i_ckey>
            <pubyear>2006</pubyear>
            <edition>In-Process</edition>
            <TSAuthorList>
                <Entity>
                    <DisplayName ValidYN="Y">Krishnan, Sitaraman</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Ward, Rebekah J</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Hexemer, Alexander</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Sohn, Karen E</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Lee, Kristen L</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Angert, Esther R</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Fischer, Daniel A</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Kramer, Edward J</DisplayName>
                </Entity>
                <Entity>
                    <DisplayName ValidYN="Y">Ober, Christopher K</DisplayName>
                </Entity>
            </TSAuthorList>
            <PMID>17154613</PMID>
            <DateCreated>
                <Year>2006</Year>
                <Month>12</Month>
                <Day>12</Day>
            </DateCreated>
            <Article PubModel="Print">
                <Journal>
                    <ISSN IssnType="Print">0743-7463</ISSN>
                    <JournalIssue CitedMedium="Print">
                        <Volume>22</Volume>
                        <Issue>26</Issue>
                        <PubDate>
                            <Year>2006</Year>
                            <Month>Dec</Month>
                            <Day>19</Day>
                        </PubDate>
                    </JournalIssue>
                    <Title>Langmuir : the ACS journal of surfaces and colloids</Title>
                </Journal>
                <ArticleTitle>Surfaces of fluorinated pyridinium block copolymers with enhanced
                    antibacterial activity.</ArticleTitle>
                <Pagination>
                    <MedlinePgn>11255-66</MedlinePgn>
                </Pagination>
                <Abstract>
                    <AbstractText>Polystyrene-b-poly(4-vinylpyridine) copolymers were quaternized
                        with 1-bromohexane and 6-perfluorooctyl-1-bromohexane. Surfaces prepared
                        from these polymers were characterized by contact angle measurements,
                        near-edge X-ray absorption fine structure spectroscopy and X-ray
                        photoelectron spectroscopy. The fluorinated pyridinium surfaces showed
                        enhanced antibacterial activity compared to their nonfluorinated
                        counterparts. Even a polymer with a relatively low molecular weight
                        pyridinium block showed high antimicrobial activity. The bactericidal effect
                        was found to be related to the molecular composition and organization in the
                        top 2-3 nm of the surface and increased with increasing hydrophilicity and
                        pyridinium concentration of the surface.</AbstractText>
                </Abstract>
                <Affiliation>Department of Materials Science and Engineering, Cornell University,
                    Ithaca, NY 14853, USA.</Affiliation>
                <AuthorList CompleteYN="Y">
                    <Author ValidYN="Y">
                        <LastName>Krishnan</LastName>
                        <ForeName>Sitaraman</ForeName>
                        <Initials>S</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Ward</LastName>
                        <ForeName>Rebekah J</ForeName>
                        <Initials>RJ</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Hexemer</LastName>
                        <ForeName>Alexander</ForeName>
                        <Initials>A</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Sohn</LastName>
                        <ForeName>Karen E</ForeName>
                        <Initials>KE</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Lee</LastName>
                        <ForeName>Kristen L</ForeName>
                        <Initials>KL</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Angert</LastName>
                        <ForeName>Esther R</ForeName>
                        <Initials>ER</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Fischer</LastName>
                        <ForeName>Daniel A</ForeName>
                        <Initials>DA</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Kramer</LastName>
                        <ForeName>Edward J</ForeName>
                        <Initials>EJ</Initials>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Ober</LastName>
                        <ForeName>Christopher K</ForeName>
                        <Initials>CK</Initials>
                    </Author>
                </AuthorList>
                <Language>eng</Language>
                <PublicationTypeList>
                    <PublicationType>Journal Article</PublicationType>
                    <PublicationType>Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
                </PublicationTypeList>
            </Article>
            <MedlineJournalInfo>
                <Country>United States</Country>
                <MedlineTA>Langmuir</MedlineTA>
                <NlmUniqueID>9882736</NlmUniqueID>
            </MedlineJournalInfo>
            <CitationSubset>IM</CitationSubset>
        </item>
    </REC>
</RECORDS>
